Atul Sobti, executive director of sales and marketing, Hero Honda Motors Ltd has quit, after completing over seven years in the company.
Hero Honda Motors is planning to enter the scooter market with its first launch slated for year-end.
Ranbaxy Laboratories Ltd, the country's biggest drug maker by revenues, has announced aggressive growth plans for the domestic market. It has increased its sales teams in specific areas like cardiovascular, diabetics and dermatology and plans to introduce over 100 new products by the year-end.
After decades of hunt for fortune abroad, India's pharmaceutical companies now plan to strike gold in their own backyard. Large players from Ranbaxy to Dr Reddy's and Piramal Healthcare are all headed to rural India to boost their revenues.
The company had a PAT of $139 million (Rs 693.1 crore) in the corresponding June quarter last year.
'It might take 10 years before medicines of decent quality and price reach right down to the last village of India. Ranbaxy, with its India focus, intends to get there in five years.'
Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib.
Two-wheeler major Hero Honda on Thursday launched its latest deluxe segment bike 'Glamour', fitted with a newly developed engine by Japanese partner Honda's research & development team.
Hero Honda Motors, India's biggest motorcycle maker, has scaled up sales target by 20 per cent this fiscal and will launch a motorcycle in the last quarter of 2004-05, a top company official said on Friday.
Deepa Gahlot lists some interesting made-for-OTT hostage dramas that you can watch.
The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points
Focus on the best you can do with what you've been given.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances